The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

BACKGROUND: Despite recent advances through the development pipeline, how novel tuberculosis (TB) vaccines might affect rifampicin-resistant and multidrug-resistant tuberculosis (RR/MDR-TB) is unknown. We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical no...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Med
Autori principali: Weerasuriya, Chathika K, Harris, Rebecca C, McQuaid, C Finn, Bozzani, Fiammetta, Ruan, Yunzhou, Li, Renzhong, Li, Tao, Rade, Kirankumar, Rao, Raghuram, Ginsberg, Ann M, Gomez, Gabriela B, White, Richard G
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7908776/
https://ncbi.nlm.nih.gov/pubmed/33632218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-01932-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi